학술논문
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors
Document Type
Article
Author
Muik, A.; Gieseke, F.; Schoedel, K.B.; Sänger, B.; Quinkhardt, J.; Toker, A.; Diken, M.; Kreiter, S.; Lagkadinou, E.; Türeci, Ö.; Şahin, U.; Garralda, E.; Alonso, G.; Altintas, I.; Burm, S.M.; Verzijl, D.; Sette, A.; Plantinga, T.S.; Van Den Brink, E.N.; Satijn, D.; Breij, E.C.W.; Geva, R.; Ben-Ami, E.; Maurice-Dror, C.; Calvo, E.; Lorusso, P.M.; Rodriguez-Ruiz, M.E.; Blum, J.M.; Salcedo, T.W.; Bajaj, G.; Sasser, K.; Ahmadi, T.; Jure-Kunkel, M.; Stanganello, E.; Vascotto, F.; Fereshteh, M.; Forssmann, U.; Melero, I.
Source
In: Cancer Discovery . (Cancer Discovery, 1 May 2022, 12(5):1248-1265)
Subject
Language
English
ISSN
21598290
21598274
21598274